Mizuho Markets Americas’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.15M | Buy |
96,072
+1,897
| +2% | +$81.9K | 0.13% | 58 |
|
|
2025
Q1 | $3.26M | Buy |
94,175
+4,000
| +4% | +$138K | 0.07% | 96 |
|
|
2024
Q4 | $2.47M | Buy |
90,175
+2,995
| +3% | +$82.2K | 0.04% | 175 |
|
|
2024
Q3 | $2.22M | Buy |
87,180
+3,198
| +4% | +$81.4K | 0.05% | 143 |
|
|
2024
Q2 | $2.13M | Buy |
83,982
+9,673
| +13% | +$245K | 0.05% | 161 |
|
|
2024
Q1 | $2.3M | Buy |
74,309
+9,930
| +15% | +$307K | 0.06% | 139 |
|
|
2023
Q4 | $2.6M | Sell |
64,379
-16,153
| -20% | -$652K | 0.07% | 131 |
|
|
2023
Q3 | $2.12M | Sell |
80,532
-5,916
| -7% | -$156K | 0.07% | 136 |
|
|
2023
Q2 | $1.49M | Sell |
86,448
-7,750
| -8% | -$133K | 0.1% | 26 |
|
|
2023
Q1 | $1.56M | Buy |
94,198
+4,600
| +5% | +$76.3K | 0.06% | 60 |
|
|
2022
Q4 | $683K | Buy |
89,598
+5,000
| +6% | +$38.1K | 0.04% | 102 |
|
|
2022
Q3 | $841K | Hold |
84,598
| – | – | 0.04% | 104 |
|
|
2022
Q2 | $768K | Sell |
84,598
-7,600
| -8% | -$69K | 0.06% | 62 |
|
|
2022
Q1 | $936K | Sell |
92,198
-42,300
| -31% | -$429K | 0.06% | 44 |
|
|
2021
Q4 | $2.24M | Sell |
134,498
-48,230
| -26% | -$804K | 0.12% | 36 |
|
|
2021
Q3 | $8.56M | Sell |
182,728
-10,998
| -6% | -$515K | 0.68% | 22 |
|
|
2021
Q2 | $11.8M | Buy |
193,726
+21,803
| +13% | +$1.33M | 1.39% | 14 |
|
|
2021
Q1 | $10.6M | Buy |
+171,923
| New | +$10.6M | 4.93% | 8 |
|